Santen Pharmaceutical Co., Ltd. (SNPHY) Financials

SNPHY Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 2.5 billion 712.0 million
March 31, 2026 2.7 billion 798.6 million
Dec. 31, 2025 2.6 billion 758.4 million
Sept. 30, 2025 2.6 billion 780.6 million

SNPHY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 26.8 million ?
March 31, 2026 123.5 million ?
Dec. 31, 2025 48.8 million ?
Sept. 30, 2025 30.0 million ?

SNPHY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 44.8 million
March 31, 2026 99.1 million
Dec. 31, 2025 51.2 million
Sept. 30, 2025 55.4 million

SNPHY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 478.0 million - -
March 31, 2026 508.5 million - -
Dec. 31, 2025 393.1 million - -
Sept. 30, 2025 446.5 million - -

SNPHY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.0 million
March 31, 2026 2.0 million
Dec. 31, 2025 2.1 million
Sept. 30, 2025 2.3 million

SNPHY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5.9 million 38.9 million - -
March 31, 2026 11.7 million 49.8 million - -
Dec. 31, 2025 10.2 million 39.0 million - -
Sept. 30, 2025 10.6 million 42.4 million - -

SNPHY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 429.6 million 194.8 million
March 31, 2026 515.5 million 198.8 million
Dec. 31, 2025 473.6 million 223.2 million
Sept. 30, 2025 475.3 million 215.4 million

SNPHY

Price: $11.82

52 week price:
9.22
13.93

Dividend Yield: 1.81%

Earnings Per Share: 0.73 USD

P/E Ratio: 15.19

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 3.4 billion

Links: